INTRODUCTION
============

Titanium dioxide (TiO~2~) nanoparticles have been used as a white pigment in paint, a food-coloring agent and a wastewater remediation agent [@B017]; [@B014]; [@B005]. Additionally, they have been widely used as an ultraviolet blocker in sunscreens [@B021]. Recently, researchers have investigated whether TiO~2~ nanoparticles may been also useful as a photocatalyst and as an important material of solar cells. In addition, studies are being conducted to establish new approaches for medical treatment using photosensitive TiO~2~ nanoparticles [@B008]. TiO~2~ nanoparticles may be applicable to various coating or surface treatment processes. Therefore, widespread human exposure may occur during the production processes and applications of TiO~2~ nanoparticles.

Upon inhalation, TiO~2~ nanoparticles are deposited in all regions of the respiratory system and distributed into other organs through cardiovascular circulation. Previous studies have reported cases of TiO~2~-induced fibrosis [@B004]; [@B007] and lung inflammation [@B016]; [@B009]; [@B020]; [@B026]. In 2006, the International Agency for Research on Cancer (IARC) classified pigmentgrade TiO~2~ as a group 2B carcinogen, which may be harmful to humans [@B002]. Furthermore, the Workplace Hazardous Materials Information System (WHMIS) groups TiO~2~ as D2A, which indicates chemical carcinogenic risk to humans. Therefore, it is necessary to assess the risk of TiO~2~ nanoparticles and to collect toxicity information, since they are still in use, but possibly carcinogenic.

In this study, we exposed male Wistar rats to dispersed aerosols of TiO~2~ nanoparticles using a nanoparticle generator (SIBATA, Japan), which was used to distribute a consistent concentration of nanoparticles (11.39 ± 0.31 mg/m^3^) to animals for 2 weeks (6 h/day, 5 days/week). Considering the potential health effects of nanoparticles, we suggest that examination of chronic effects from exposure is more important than assessment of fetal injuries associated with acute response. For that reason, we conducted this study for 2 weeks and compared our results with those from previous TiO~2~ inhalation toxicity studies that were carried out for 5 days [@B007]; [@B026]; [@B015] or 13 weeks [@B003]; [@B004].

MATERIALS AND METHODS
=====================

***Test material and TiO~2~ nanoparticle generation.*** TiO~2~ (Titanium dioxide, 811X1240) nanoparticles were obtained from KANTO CHEMICAL Corporation (Japan). To generate TiO~2~ nanoparticles, we dispersed test material in distilled water at a concentration of 0.4% w/w. We generated the test material suspension using a nanoparticle generator connected to a nose-only exposure system (SIBATA, Japan). The nanoparticle generator consisted of 3 main parts, including a nebulizer for spraying test materials, a heater to blow away the solvent of the aerosol, and a neutralizer for removing the charges of the materials. The treated group of animals were exposed to the generated aerosols for 2 weeks (6 h/day, 5 days/week). We determined the target mass concentration of approximately 10 mg/m^3^ using the scanning mobility particle sizer (SMPS) 3034 (TSI, USA). The control animal group was exposed to clean air only.

***Animals and conditions.*** This study was conducted using 7 week-old male Crl:WI (Han) Wistar rats that were obtained from Orient Bio (Korea). The animals were acclimated for 10 days before we began the study. The rats were maintained in cages at 23 ± 3℃, with relative humidity of 50 ± 10%, and a 12 hour light-dark cycle. The rats were fed rodent diet (Labdiet; PMI Nutrition International Inc., USA) and filtered water *ad libitum*. The animals were examined for clinical signs once a day for the duration of exposure. After 2 weeks of exposure, we conducted necropsies at 1, 7, and 15 days. Subsequently, we weighed the organs, performed histopathological examination, and analyzed the bronchoalveolar lavage fluid (BALF) and serum for 6\~7 animals at each time point ([Table 1](#T001){ref-type="table"}). This study was carried out in compliance with the Association for Assessment and Accreditation of Laboratory Animal Care.

###### 

Study design

  ------------------------------------ ------ ----------- ------- ----------- ------- ------------
  Study day                            1-10   11          12-16   17          18-24   25
                                                                                      
  Study phase                          EP     R           R       R           R       R
  Examinations and their time points          N (Day 1)           N (Day 7)           N (Day 15)
  ------------------------------------ ------ ----------- ------- ----------- ------- ------------

EP = Nose-only exposure for 6 hours a day, R = Recovery period; N = Necropsy, organ weight, histopathology, and BALF.

***Biochemistry in BAL fluid and serum.*** On 1, 7 and 15 days post-exposure, bronchoalveolar lavage fluid (BALF) was collected. The right lung was lavaged 3 times with 15 ml (22 ml/kg body weight) of 0.9% (w/v) saline to obtain the BALF from animals. The BALF samples were centrifuged (600 g, 10 min, 4℃) and their supernatants were analyzed with a FUJI DRI-CHEM FDC3500 (FUJIFILM, Japan) for activities of lactate dehydrogenase (LDH), γ- glutamyltransferase (GGT), and alkaline phosphatase (ALP). We also determined the total cell count in BALF with a Vi-CELL (Beckman Coulter, USA). Differential cell counts were performed on cytocentrifuged preparations and stained with Wright-Giemsa. The blood from abdominal vein was centrifuged (1600 g, 15 min, 4℃) and the resultant supernatants were stored at −80℃ for further biochemical analyses. To be specific, we determined levels of lactate dehydrogenase (LDH), and blood urea nitrogen (BUN), total protein (TP) in serum using a FUJI DRI-CHEM FDC3500.

***Histopathology.*** Necropsies were performed at 1, 7, and 15 days post-exposure. Rats were euthanized by isoflurane anesthesia. Blood was collected from abdominal vein. We obtained the lungs, livers, and nasal cavities from animals after necropsy and measured the organs weights. The lungs and nasal cavities were fixed in a 10% natural formalin solution for further histopathological diagnosis. Paraffinembedded tissues were sectioned, stained with hematoxylin and eosin (H&E), and examined by light microscopy.

***Statistical analysis.*** Each of the experimental values was compared to the corresponding control value for each time point using Student's *t*-test. Comparisons were considered statistically significant when *p* \< 0.05.

RESULTS
=======

***Test material analysis.*** TiO~2~ nanoparticles consisted of anatase as the major crystal phase from the XRD (X-ray diffractometry) pattern (Data not shown). Briefly, we obtained the volume ratio of the two crystal phases, 100 of anatase phase and 5.8 of rutile phase. Thus, it was noted that approximately 5.5% volume of the rutile phase existed in the nanoparticles. Furthermore, we calculated the mean crystallite size of TiO~2~ nanoparticles using the full width at half maximum of peaks and the Scherrer formula. Anatase and rutile phases revealed mean crystallite sizes of 52.6 nm and 60.9 nm, respectively. In addition, TiO~2~ nanoparticles seemed not to be charged, but instead neutral from fourier transform infrared spectroscopy (FT-IR) spectrum (Data not shown). [Fig. 1](#F001){ref-type="fig"} shows the morphological characteristics of TiO~2~ nanoparticles, which exhibited a wide range of sizes with a few particles up to 100 nm. We also observed that the particles have mostly spherical shapes and the presence of some agglomerated nanoparticles.

![TEM micrograph of TiO~2~ nanoparticles obtained at the magnification of 200,000 ×. The morphological characteristics of TiO~2~ nanoparticles are shown, which exhibit a wide range of size, with a few particles up to 100 nm. The particle shape was mostly spherical. Agglomerated TiO~2~ nanoparticles were also found. TEM: Transmission electron microscopy.](toxicr-28-217-g001){#F001}

![The size distribution was monitored using the SMPS during inhalation exposure periods. It shows the representative distribution of the sizes of TiO~2~ nanoparticles. SMPS: Scanning mobility particle sizer.](toxicr-28-217-g002){#F002}

![In the nose-only inhalation chamber, mean mass concentration of TiO~2~ nanoparticles were determined to be 11.39 ± 0.31 mg/m^3^. Error bar means standard deviation of each exposure day.](toxicr-28-217-g003){#F003}

***Particle concentration in the chamber.*** We also evaluated the size distribution of nanoparticles in the chamber using a SMPS during inhalation exposure periods. [Fig. 2](#F002){ref-type="fig"} shows the representative data from this analysis. By controlling the generation of the airflow and the dilution of the airflow of the nanoparticle generator, we could maintain the mean mass concentration of TiO~2~ nanoparticles as 11.39 ± 0.31 mg/m^3^ ([Fig. 3](#F003){ref-type="fig"}). Furthermore, we obtained the geometric mean diameter (GMD) and total number concentration during inhalation exposure periods. The mean GMD (nm) ± geometrical standard deviation (GSD) and total number concentration was determined to be 79.19 ± 4.41 nm and 1.8 × 10^6^ particles/cm^3^, respectively (Data not shown).

![Body weight change of rats exposed to TiO~2~ nanoparticles. There were no significant differences between the control and treated group. The data are presented as the mean (g) ± SD.](toxicr-28-217-g004){#F004}

***Animal observations, body weights, and organ weights.*** There was no significant clinical sign induced by TiO~2~ nanoparticles for the study durations. Body weight was measured prior to inhalation exposure and at 1, 7 and 15 days post-exposure. In all groups, body weights were increased with the passage of time ([Fig. 4](#F004){ref-type="fig"}) but there were no statistically significant changes. [Table 2](#T002){ref-type="table"} shows that calculated relative organ weights (i.e. lung, liver and spleen) to mean body weight of each group. Increased weight of the spleen of all groups was caused by increasing their body weight. There were no significant changes of liver and lung weights.

###### 

Absolute and relative organ weights

  ---------------------- --------------------- --------------------- ---------------------- ---------------- ---------------- ----------------
                         Day 1 post-exposure   Day 7 post-exposure   Day 15 post-exposure                                     
                                                                                                                              
  Control                Treated               Control               Treated                Control          Treated          
                                                                                                                              
  Necropsy body weight   367.91 ± 14.61        359.87 ± 22.81        386.97 ± 27.29         385.48 ± 23.53   415.66 ± 16.32   410.95 ± 26.26
  Lung                                                                                                                        
  Absolute                 0.46 ± 0.05           0.47 ± 0.04           0.47 ± 0.07            0.47 ± 0.04      0.49 ± 0.05      0.49 ± 0.02
  Relative                 0.12 ± 0.01           0.13 ± 0.01           0.12 ± 0.01            0.12 ± 0.02      0.12 ± 0.01      0.12 ± 0.01
  Liver                                                                                                                       
  Absolute               13.52 ± 1.60          13.11 ± 1.56          13.25 ± 2.79           14.73 ± 1.20     14.28 ± 0.89     14.59 ± 1.26
  Relative                 3.67±0.43             3.64 ± 0.43           3.42 ± 0.72            3.82 ± 0.31      3.44 ± 0.21      3.55 ± 0.31
  Spleen                                                                                                                      
  Absolute                 0.79 ± 0.08           0.75 ± 0.11           0.85 ± 0.17            0.94 ± 0.16      1.03 ± 0.05      0.93 ± 0.10
  Relative                 0.22 ± 0.02           0.21 ± 0.03           0.22 ± 0.04            0.24 ± 0.04      0.25 ± 0.01      0.23 ± 0.02
  ---------------------- --------------------- --------------------- ---------------------- ---------------- ---------------- ----------------

Note: All values are presented as the mean (g) ± standard deviation for the indicated animal groups.

###### 

BALF cytology of rats exposed to TiO~2~ nanoparticles

  ------------ --------------------- --------------------- ---------------------- --------- --------- -------
  Cell type    Day 1 post-exposure   Day 7 post-exposure   Day 15 post-exposure                       
                                                                                                      
  Control      Treated               Control               Treated                Control   Treated   
                                                                                                      
  Total cell   5.246                 5.361                 4.166                  4.230     4.650     4.780
  Macrophage   5.230                 5.356                 4.153                  4.221     4.640     4.716
  Neutrophil   0.003                 0.004                 0.008                  0.005     0.004     0.008
  Lymphocyte   0.013                 0.002                 0.005                  0.004     0.006     0.057
  ------------ --------------------- --------------------- ---------------------- --------- --------- -------

Note: Rats were treated with 0 (control) or 11.39 mg/m^3^ (Treatment) TiO~2~ nanoparticles by inhalation for 2 weeks. Lung lavage was performed on 1,7, and 15 days post-exposure.

Mean values {(Cell counts/ml BALF) × 10^5^} of the indicated animal groups are shown.

###### 

Biochemical parameters in BALF and serum after exposure of TiO~2~ nanoparticles

  --------- --------------------- --------------------- ---------------------- ----------------- ----------------- ----------------- ----------------
            Day 1 post-exposure   Day 7 post-exposure   Day 15 post-exposure                                                         
                                                                                                                                     
  Control   Treated               Control               Treated                Control           Treated                             
                                                                                                                                     
  BALF      LDH                     1.33 ± 0.82           1.14 ± 0.38            2.00 ± 1.41       1.67 ± 1.63       1.75 ± 5.96       1.50 ± 2.07
  GGT       10.00 ± 2.58            8.86 ± 1.07           9.86 ± 2.41            9.00 ± 0.89       8.67 ± 1.03       8.00 ± 1.67     
  ALP       17.57 ± 3.55          14.57 ± 3.60          16.71 ± 4.23           19.83 ± 3.25      19.67 ± 6.95      25.67 ± 6.62      
            Day 1 post-exposure   Day 7 post-exposure   Day 15 post-exposure                                                         
                                                                                                                                     
  Control   Treated               Control               Treated                Control           Treated                             
                                                                                                                                     
  Serum     LDH                   820.86 ± 62.34        771.33 ± 154.30        703.57 ± 171.52   728.00 ± 181.43   641.50 ± 232.23   729.50 ± 87.55
  BUN       13.73 ± 0.69          15.29 ± 2.29          17.29 ± 6.10           14.22 ± 1.14      19.35 ± 4.39      20.48 ± 4.48      
  TP          5.17 ± 0.19           5.41 ± 0.19           5.17 ± 0.18            5.13 ± 0.19       5.40 ± 0.18       5.52 ± 0.16     
  --------- --------------------- --------------------- ---------------------- ----------------- ----------------- ----------------- ----------------

Note: All values are presented as the mean (U/L) ± standard deviation for the indicated animal groups.

BALF: Bronchoalveolar lavage fluid, LDH: Lactate dehydrogenase, ALP: Alkaline phosphatase, GGT: γ-glutamyltransferase, BUN: Blood urea nitrogen, TP: Total protein

***BAL fluid cytology and biochemical parameters in BAL fluid and serum.*** Results of BAL fluid cytology show that the total cell number and macrophage value were highest at 1 day post-exposure ([Table 3](#T003){ref-type="table"}). In treated group, total cell number and macrophage value were higher than control group of each time point. However there was no statistical significance between control and treated group. In addition, there were no differences in biochemical parameters of LDH, ALP, and GGT in BAL fluid and LDH, BUN, and TP in serum of all rats ([Table 4](#T004){ref-type="table"}).

***Histopathological examination.*** Upon examination of the lung tissues of all treated rats, we observed numerous brown pigmented macrophages in alveoli until 15 days post-exposure ([Fig. 5](#F005){ref-type="fig"}). At 1 day post-exposure, we found olfactory epithelium degeneration/regeneration with inflammatory cell infiltration on the nasal septum and ethmoid turbinate of the treated rats. Besides, we observed basal cell proliferation on the ethmoid turbinate at 7 day post-exposure. However, these lesions were not observed at 15 days post-exposure ([Fig. 6](#F006){ref-type="fig"}).

![Histopathological examination was performed in the lungs of rats exposed to TiO~2~ nanoparticles for 2 weeks. (A) Lung of control rat. (B) Day 1 post-exposure. (C) Day 7 postexposure. (D) Day 15 post-exposure. Arrows indicate pigmented macrophages in alveoli. Hematoxylin and eosin, 400 × magnification.](toxicr-28-217-g005){#F005}

![Histopathological examination of the nasal cavities of rats exposed to TiO~2~ nanoparticles for 2 weeks. (A, B) Nasal cavity of control rat. (C, D) Nasal cavity of rat sacrificed at day 1 post-exposure. Moderate olfactory degeneration/regeneration with inflammatory cell infiltration was observed on the nasal septum and ethmoid turbinate (arrows) (E, F) Nasal cavity of rat sacrificed at day 7 postexposure. Besides, olfactory degeneration/regeneration was observed on the nasal septum and ethmoid turbinate (arrows). Also, basal cell proliferation was observed on the ethmoid turbinate (arrow head). (G, H) Nasal cavity of rat sacrificed at day 15 post-exposure. Lesions were not observed. Hematoxylin and eosin, A, C, E, G: 40 × magnification; B, D, F, H: 200 × magnification.](toxicr-28-217-g006){#F006}

DISCUSSION
==========

The aim of this study is to examine the influence of TiO~2~ nanoparticles on rats that were exposed using a system for nose-only exposure. Rats in the treated group were exposed to a mass concentration of 11.39 mg/m^3^ for 2 weeks; control rats were exposed to clean air only. We did not observed changes in clinical signs, body weights and organ weight, cells of the BALF, biochemical parameters and cytokines on BALF and serum during the study. In general, total cell counts, LDH, TP levels and other enzyme activities represent parameters of cell injury in toxicity studies including nanoparticles [@B007]; [@B004]; [@B004]; [@B026]; [@B015]. In this study, we did not observe any significant differences between the control and treated groups in terms of these factors. Also, IL-6, an important immune modulation mediator, is generally known to function in acute inflammation. As cell activators, IL-4 and IL-10 are cytokines of the Th2-type. Specially, IL-10 is related to the fibrotic process and chronic inflammation [@B020]. In this study, we did not observe significant differences in levels of IL-4, IL-6, or IL-10 between the control and treated groups on 1, 7, and 15 days postexposure (Data not shown). However, upon examination of stained BALF cell (1000 × magnification) with a microscope, we found phagocytosed macrophages of all the treated rats (Data not shown). This result suggests that the concentration of TiO~2~ nanoparticles that we exposed to rat was not high enough to activate the immune cells. Instead, the concentration we used was sufficient to control macrophages in alveoli. [@B003] also noted no signs of inflammation upon histopathological observation of 6-week-old female rats exposed to 10 mg/m^3^ TiO~2~ concentration for 13 weeks (6 hr/day, 5 days/week). However, other studies indicated toxicological changes when nanoparticles were phagocyted by macrophage. It is the case that exposure period is sufficiently long and particle concentration is high to cause inflammation.

###### 

The delivered amounts of TiO~2~ nanoparticles to rats

  ---------------- -------------------- --------------------------------- --------------------- --------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference        Particle size (nm)   Aerosol concentration (mg/m^3^)   Exposure time (min)   Delivered TiO~2~ amounts (mg/rat)^a)^   Degree of toxicity
                                                                                                                                        
  [@B004]          21                   0.52                              23400                 0.63                                    No histopathological lesions in lung, No changes in BALF cell parameter or lung burdens
  [@B015]          25.1                 2.4                               1800                  1.08                                    No effect on the BALF parameters
  [@B004]          21                   2.1                               23400                 2.56                                    No histopathological lesions in lungs, No changes in BALF cell parameter or lung burdens
  [@B015]          25.1                 12.1                              1800                  5.45                                    Increase in BALF cell counts, total protein levels, and enzyme activities
  **This study**   **79**               **11.39**                         **3600**              **10.27**                               **No effect on the BALF parameters and biochemistry in BALF and serum, Mild degeneration/ regeneration of olfactory in nasal cavity, lung infiltration of macrophage**
  [@B003]          Pigment grade        9.6                               23400                 11.72                                   No response to inflammation
  [@B004]          21                   10.5                              23400                 12.82                                   Increased number of macrophages and neutrophils in BALF, Pulmonary particle overload, epithelial and fibroproliferative changes
  [@B007]          Pigment grade        51.1                              1800                  13.59                                   No changes in BALF biochemistry, cellular parameter, or histopathological examination.
  [@B015]          25.1                 50.0                              1800                  22.53                                   Increase in lung weight, BALF cell counts, total protein levels, and enzyme activities Histopathological lesions in the nasal epithelium
  [@B026]          20\~30               88.0                              1800                  39.66                                   Increase in lung weight, neutrophilic inflammation, and activation of macrophages in the lung
  [@B003]          Pigment grade        47.7                              23400                 58.22                                   Increase in BALF cell number, LDH level in BALF
  [@B003]          Pigment grade        239.1                             23400                 291.85                                  Increase in BALF cell number, LDH and TP levels in BALF, and epithelial and fibroproliferative changes
  ---------------- -------------------- --------------------------------- --------------------- --------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

a\) Actual delivered TiO~2~ amounts (mg/kg) = (Aerosol concentration × RMV× Exposure time). RMV: respiratory minute volume (L/min) = 0.608 × BW(kg)^0.852^.

Note: Delivered TiO~2~ amounts were calculated according to the article by [@B001]. Reference of the body weight was according to Bermudez *et al*.: [www.Lapanimal.co.kr](www.Lapanimal.co.kr).

The actual delivered amounts of TiO~2~ nanoparticles that are exposed to rats can be calculated by multiplying the aerosol concentration of TiO~2~ nanoparticles by the amount of inhaled air by rats, which was previously reported by [@B001]. [Table 5](#T005){ref-type="table"} shows the estimation data that we calculated by this formula using the aerosol concentration of TiO~2~ nanoparticles and the animals' mean body weights from the data of several inhalation studies. From this table, we concluded that the exposure amount used in this study is comparatively low (10.27 mg/rat) in comparison to other studies that indicated toxicity. In this method, we concluded an aspect of correspondence between the actual exposure levels and toxicity degree. When the rats inhaled higher amounts of nanoparticle, the toxic responses were more severe. In addition, we have to consider the size of nanoparticle. We measured that mean particle size of approximately 80 nm in actual exposure atmosphere during study period. As we already know, the toxicity increases as the size of nanoparticles decreases [@B022] due to the high reactivity between nanoparticles with large surface area and because materials of the body [@B018]; [@B028]; [@B006]; [@B029]. In the study carried out by [@B015], these results represent more toxic than other studies because of their small size.

We could not observe any changes in biochemical parameters. However, we observed that macrophages infiltrated TiO~2~ nanoparticles in alveoli of treated rats until 15 days post-exposure. These findings are in line with the results of a previous inhalation study by [@B004], which showed degeneration and thickness of lung epithelial cells and particle-laden macrophages of the alveolar region. In our study, histopathological examination of nasal cavity of rats at 1 day post-exposure revealed that TiO~2~ nanoparticles induced olfactory epithelium degeneration/regeneration which was recovered by 15 days post-exposure. Several studies have observed toxicity in the nasal cavity of animals after exposure to nanoparticles. For instance, [@B024] observed deposited carbon black nanoparticles in the nasal cavities of BALB/c mice after intranasal instillation once a week for 4 weeks. It has been also reported that ultrafine silver nanoparticles were deposited on the posterior portion of nasal cavities of female Fischer rats after exposure [@B023]. Furthermore, the previous report of Korea National Toxicology Program, [@B012] demonstrated that ICR mice subjected to nose-only exposure with amorphous silica for 4 weeks exhibited focal histopathological changes in their nasal cavities. In the report, biochemical changes (LDH, total protein, BUN, glucose, total bilirubin and etc.) were observed. In another study including head-nose exposure with nano- TiO~2~ at 88 mg/m^3^, particles were observed in the olfactory epithelium of nasal cavities [@B026]. Additionally, there were studies that showed histopathological lesions in the nasal epithelium of rats after exposure to TiO~2~ nanoparticles at concentration of 50 mg/m^3^ [@B015] and increases in the incidence of pneumonia, trachitis and rhinitis with squamous metaplasia in the anterior nasal cavity of CD rats exposed TiO~2~ for 2 years [@B013].

Compared to delivered amount of TiO~2~ nanoparticle to rats in the table, it is apparent that the table represents doseresponse toxicological changes. In our study, where TiO~2~ was exposed to \~11 mg/m^3^ for 2 weeks, we observed histopathological lesions of nasal cavity of treated rats. Among the studies showing toxicity of nasal cavity, it is related to the exposure concentration of inhaled nanoparticles whether the results represent biochemical changes or not.

Inhaled nanoparticles into the body contact with the nasal cavity first and this area is open to outer space. Deposited nanoparticles in the nasal cavity have potential toxicity; they could be translocated to other organs, especially the brain. A previous study reported that TiO~2~ nanoparticles translocated into the central nervous system and potentially caused lesions of the brain [@B027]. This study is in agreement with other previous studies that showed, following inhalation exposure, nanoparticles traveled via the nasal nerves to the brain [@B011]; [@B019]. Other studies have also indicated that the olfactory route may be an important transfer route for inhaled nanoparticles to the central nervous system [@B018]; [@B012]; [@B010]; [@B025]. Therefore, we need to consider the nasal cavity for accomplishment the study of inhalation toxicity.

We observed nasal and pulmonary toxicity which was reversible at the concentration approximately 11 mg/m^3^ of TiO~2~ nanoparticles and without any other biochemical changes. This study can serve as an example of investigation of the influence of TiO~2~ nanoparticles of rats upon nose-only exposure, and can be used to guide future studies designed to estimate nanotoxicity and examine other similar nanoparticles.
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